{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:14:37Z","timestamp":1777486477048,"version":"3.51.4"},"reference-count":34,"publisher":"Japanese Society of Toxicology","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2025]]},"DOI":"10.2131\/jts.50.547","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:02Z","timestamp":1759270082000},"page":"547-554","source":"Crossref","is-referenced-by-count":2,"title":["Successful multimodal treatment of venlafaxine overdose-induced catecholamine-refractory shock: a case report"],"prefix":"10.2131","volume":"50","author":[{"given":"Tomoaki","family":"Hayakawa","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Nagoya City University Hospital"},{"name":"Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimasa","family":"Sanagawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nagoya City University Hospital"},{"name":"Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences"},{"name":"Department of Pharmacy, Faculty of Medicine, Mie University Hospital, Mie University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nagoya City University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Kotoge","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Nagoya City University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Nagoya City University Hospital"},{"name":"Department of Advancing Acute Medicine, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Monma-Otaki","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Furukawa-Hibi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Nagoya City University Hospital"},{"name":"Department of Clinical Pharmaceutics, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Nagoya City University Hospital"},{"name":"Department of Advancing Acute Medicine, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Batista, M., Dugernier, T., Simon, M., Haufroid, V., Capron, A., Fonseca, S., Bonbled, F. and Hantson, P. (2013): The spectrum of acute heart failure after venlafaxine overdose. Clin. Toxicol. (Phila.), <b>51<\/b>, 92-95.","DOI":"10.3109\/15563650.2012.763133"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Blythe, D. and Hackett, L.P. (1999): Cardiovascular and neurological toxicity of venlafaxine. Hum. Exp. Toxicol., <b>18<\/b>, 309-313.","DOI":"10.1191\/096032799678840165"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Castanares-Zapatero, D., Gillard, N., Capron, A., Haufroid, V. and Hantson, P. (2016): Reversible cardiac dysfunction after venlafaxine overdose and possible influence of genotype and metabolism. Forensic Sci. Int., <b>266<\/b>, e48-e51.","DOI":"10.1016\/j.forsciint.2016.05.030"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Christoph, M., Ebner, B., Stolte, D., Ibrahim, K., Kolschmann, S., Strasser, R.H. and Sch\u00f6n, S. (2010): Broken heart syndrome: tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur. Neuropsychopharmacol., <b>20<\/b>, 594-597.","DOI":"10.1016\/j.euroneuro.2010.03.009"},{"key":"5","doi-asserted-by":"publisher","unstructured":"Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S.E., Qin, B., Whittington, C., Coghill, D., Zhang, Y., Hazell, P., Leucht, S., Cuijpers, P., Pu, J., Cohen, D., Ravindran, A.V., Liu, Y., Michael, K.D., Yang, L., Liu, L. and Xie, P. (2016): Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet, <b>388<\/b>, 881-890.","DOI":"10.1016\/S0140-6736(16)30385-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Couderc, S., Gabriel, A., Decheiver, S., N\u2019Zou\u00e9 Kanga, S., Fikanni, A., Flint, H., Pihan, F., Sahar, A., Tifrea, M., Tifrea, A., Marsaud, J.P. and Vandroux, D. (2024): A massive venlafaxine intoxication: Evolution of cardiac toxicity with venlafaxine and o-desmethylvenlafaxine elimination kinetics: A grand round. Ther. Drug Monit., <b>46<\/b>, 133-137.","DOI":"10.1097\/FTD.0000000000001167"},{"key":"7","doi-asserted-by":"crossref","unstructured":"de Wit, D., Franssen, E.J. and Verstoep, N. (2022): Intralipid administration in case of a severe venlafaxine overdose in a patient with previous gastric bypass surgery. Toxicol. Rep., <b>9<\/b>, 1139-1141.","DOI":"10.1016\/j.toxrep.2022.05.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Forsberg, S., Abazi, L. and Forsman, P. (2021): Successful use of extended cardiopulmonary resuscitation followed by extracorporeal oxygenation after venlafaxine-induced takotsubo cardiomyopathy and cardiac arrest: a case report. J. Med. Case Rep., <b>15<\/b>, 485.","DOI":"10.1186\/s13256-021-03031-w"},{"key":"9","doi-asserted-by":"publisher","unstructured":"Foster, C.A., O\u2019Mullane, E.J., Gaskell, P. and Churchill-Davidson, H.C. (1954): Chlorpromazine: a study of its action on the circulation in man. Lancet, <b>267<\/b>, 614-617.","DOI":"10.1016\/S0140-6736(54)90400-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Higuchi, H., Yabuki, A., Ishii-Maruhama, M., Tomoyasu, Y., Maeda, S. and Miyawaki, T. (2014): Hemodynamic changes by drug interaction of adrenaline with chlorpromazine. Anesth. Prog., <b>61<\/b>, 150-154.","DOI":"10.2344\/0003-3006-61.4.150"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Hoffmann, M., Akbas, S., Kindler, R. and Bettex, D. (2024): Successful use of extracorporeal life support and hemadsorption in the context of venlafaxine intoxication requiring cardiopulmonary resuscitation: a case report. J. Artif. Organs, <b>27<\/b>, 167-171.","DOI":"10.1007\/s10047-023-01399-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"H\u00f6jer, J., Hulting, J. and Salmonson, H. (2008): Fatal cardiotoxicity induced by venlafaxine overdosage. Clin. Toxicol. (Phila.), <b>46<\/b>, 336-337.","DOI":"10.1080\/15563650701358755"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Hwang, Y. and Sohn, J.T. (2024): Effect of lipid emulsion on neuropsychiatric drug-induced toxicity: A narrative review. Medicine (Baltimore), <b>103<\/b>, e37612.","DOI":"10.1097\/MD.0000000000037612"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kent, J.M. (2000): SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet, <b>355<\/b>, 911-918.","DOI":"10.1016\/S0140-6736(99)11381-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Khalifa, M., Daleau, P. and Turgeon, J. (1999): Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther., <b>291<\/b>, 280-284.","DOI":"10.1016\/S0022-3565(24)35098-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kishi, T., Ikuta, T., Sakuma, K., Okuya, M., Hatano, M., Matsuda, Y. and Iwata, N. (2023): Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis. Mol. Psychiatry, <b>28<\/b>, 402-409.","DOI":"10.1038\/s41380-022-01824-z"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Klamerus, K.J., Maloney, K., Rudolph, R.L., Sisenwine, S.F., Jusko, W.J. and Chiang, S.T. (1992): Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J. Clin. Pharmacol., <b>32<\/b>, 716-724.","DOI":"10.1002\/j.1552-4604.1992.tb03875.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kumar, V.V., Isbister, G.K. and Duffull, S.B. (2011): The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose. Br. J. Clin. Pharmacol., <b>72<\/b>, 125-132.","DOI":"10.1111\/j.1365-2125.2011.03934.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kumar, V.V., Oscarsson, S., Friberg, L.E., Isbister, G.K., Hackett, L.P. and Duffull, S.B. (2009): The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin. Pharmacol. Ther., <b>86<\/b>, 403-410.","DOI":"10.1038\/clpt.2009.114"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Langford, N.J., Martin, U., Ruprah, M. and Ferner, R.E. (2002): Alternative venlafaxine kinetics in overdose. J. Clin. Pharm. Ther., <b>27<\/b>, 465-467.","DOI":"10.1046\/j.1365-2710.2002.00438.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Laurent, R., Varvat, C., Goudard, D., Delavenne, X., Gauthier, V. and Launay, M. (2021): Pharmacobezoar after venlafaxine and oxazepam overdose: how pharmacokinetics could help?-A grand round. Ther. Drug Monit., <b>43<\/b>, 143-145.","DOI":"10.1097\/FTD.0000000000000860"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Magny, R., M\u00e9garbane, B., Guillaud, P., Chevillard, L., Auzeil, N., Thiebot, P., Voicu, S., Malissin, I., Deye, N., Labat, L. and Houz\u00e9, P. (2023): Life-threatening cardiogenic shock related to venlafaxine poisoning\u2014a case report with metabolomic approach. Metabolites, <b>13<\/b>, 353.","DOI":"10.3390\/metabo13030353"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Marquetand, C., Langer, H.F., Klein, J.P. and Graf, T. (2020): The use of extracorporeal life support in a patient suffering from venlafaxine intoxication. A case report. J. Crit. Care Med. (Targu Mures), <b>6<\/b>, 120-123.","DOI":"10.2478\/jccm-2020-0014"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Martinez, C., Assimes, T.L., Mines, D., Dell\u2019aniello, S. and Suissa, S. (2010): Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. BMJ, <b>340<\/b>, c249.","DOI":"10.1136\/bmj.c249"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Murphy, L., Rasmussen, J. and Murphy, N.G. (2021): Venlafaxine overdose treated with extracorporeal life support. CMAJ, <b>193<\/b>, E167-E170.","DOI":"10.1503\/cmaj.201318"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Napp, L.C., Vogel-Claussen, J., Sch\u00e4fer, A., Haverich, A., Bauersachs, J., K\u00fchn, C. and Tongers, J. (2017): First-in-man fully percutaneous complete bypass of heart and lung. JACC Cardiovasc. Interv., <b>10<\/b>, e231-e233.","DOI":"10.1016\/j.jcin.2017.07.047"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Neil, C.J., Chong, C.R., Nguyen, T.H. and Horowitz, J.D. (2012): Occurrence of Tako-Tsubo cardiomyopathy in association with ingestion of serotonin\/noradrenaline reuptake inhibitors. Heart Lung Circ., <b>21<\/b>, 203-205.","DOI":"10.1016\/j.hlc.2011.12.004"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Nishimura, T., Hirata, Y., Ise, T., Iwano, H., Izutani, H., Kinugawa, K., Kitai, T., Ohno, T., Ohtani, T., Okumura, T., Ono, M., Satomi, K., Shiose, A., Toda, K., Tsukamoto, Y., Yamaguchi, O., Fujino, T., Hashimoto, T., Higashi, H., Higashino, A., Kondo, T., Kurobe, H., Miyoshi, T., Nakamoto, K., Nakamura, M., Saito, T., Saku, K., Shimada, S., Sonoda, H., Unai, S., Ushijima, T., Watanabe, T., Yahagi, K., Fukushima, N., Inomata, T., Kyo, S., Minamino, T., Minatoya, K., Sakata, Y. and Sawa, Y.; Japanese Circulation Society, the Japanese Society for Cardiovascular Surgery, Japanese College of Cardiology, Japanese Association of Cardiovascular Intervention and Therapeutics Joint Working Group. (2024): The JCS\/JSCVS\/JCC\/CVIT 2023 guidelines focused on updating the indication and operation of PCPS\/ECMO\/Impella. Circ. J., <b>88<\/b>, 1010-1046.","DOI":"10.1253\/circj.CJ-66-0227"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Pancrazio, J.J., Kamatchi, G.L., Roscoe, A.K. and Lynch, C. 3rd. (1998): Inhibition of neuronal Na+ channels by antidepressant drugs. J. Pharmacol. Exp. Ther., <b>284<\/b>, 208-214.","DOI":"10.1016\/S0022-3565(24)37206-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Schroeder, I., Zoller, M., Angstwurm, M., Kur, F. and Frey, L. (2017): Venlafaxine intoxication with development of takotsubo cardiomyopathy: successful use of extracorporeal life support, intravenous lipid emulsion and CytoSorb\u00ae. Int. J. Artif. Organs, <b>40<\/b>, 358-360.","DOI":"10.5301\/ijao.5000595"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Schulz, M., Schmoldt, A., Andresen-Streichert, H. and Iwersen-Bergmann, S. (2020): Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit. Care, <b>24<\/b>, 195.","DOI":"10.1186\/s13054-020-02915-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Thomas, A., Ovakim, D., Kanji, H., Dewar, L. and Finlayson, G. (2017): Intravenous lipid emulsion therapy and VA-ECMO rescue therapy for massive venlafaxine and clonazepam overdose. J. Clin. Toxicol., <b>7<\/b>, 6.","DOI":"10.4172\/2161-0495.1000368"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Vasudev, R., Rampal, U., Patel, H., Patel, K., Bikkina, M. and Shamoon, F. (2016): Selective serotonin-norepinephrine reuptake inhibitors-induced takotsubo cardiomyopathy. N. Am. J. Med. Sci., <b>8<\/b>, 312-315.","DOI":"10.4103\/1947-2714.187153"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Voicu, S., M\u2019Rad, A., Malissin, I., Deye, N. and M\u00e9garbane, B. (2023): Extracorporeal life support in cardiotoxicant poisoning-A narrative review. Basic Clin. Pharmacol. Toxicol., <b>132<\/b>, 5-20.","DOI":"10.1111\/bcpt.13804"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/10\/50_547\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:07:05Z","timestamp":1759550825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/50\/10\/50_547\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.50.547","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}